Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
28
CATX Quote, Financials, Valuation and Earnings
Last price:
$2.60
Seasonality move
:
15.93%
Day range:
$2.54 - $2.68
52-week range:
$2.32 - $19.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.99x
P/B ratio:
0.53x
Volume:
394.8K
Avg. volume:
580.3K
1-year change:
-75.79%
Market cap:
$175.1M
Revenue:
--
EPS (TTM):
-$1.46
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $3.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -67.1% | -- | |
| Cost of Revenues | -- | -- | -- | $2.7M | -- | |
| Gross Profit | -- | -- | -- | $817K | -- | |
| Gross Profit Margin | -- | -- | -- | 23% | -- | |
| R&D Expenses | -- | -- | -- | $1.3M | $21.3M | |
| Selling, General & Admin | -- | -- | -- | $7.1M | $21.1M | |
| Other Inc / (Exp) | -- | -- | -- | -$305K | -$15K | |
| Operating Expenses | -- | -- | -- | $8.4M | $40.9M | |
| Operating Income | -- | -- | -- | -$7.6M | -$40.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$7.3M | -$40.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -$9.1M | |
| Income Tax Expense | -- | -- | -- | -- | -$2.7M | |
| Net Income to Company | -- | -- | -- | -$7.3M | -$46.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$7.3M | -$46.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.50 | -$1.70 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.50 | -$1.70 | |
| Weighted Average Basic Share | -- | -- | -- | $14.2M | $26.8M | |
| Weighted Average Diluted Share | -- | -- | -- | $14.2M | $26.8M | |
| EBITDA | -- | -- | -- | -$7.5M | -$39.1M | |
| EBIT | -- | -- | -- | -$7.6M | -$40M | |
| Revenue (Reported) | -- | -- | -- | $3.6M | -- | |
| Operating Income (Reported) | -- | -- | -- | -$7.6M | -$40.9M | |
| Operating Income (Adjusted) | -- | -- | -- | -$7.6M | -$40M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4M | $2.6M | $1.7M | $1.9M | -- | |
| Revenue Growth (YoY) | 2.98% | 7.55% | -33.03% | -23.79% | -- | |
| Cost of Revenues | $1.1M | $1.5M | $1.3M | -- | -- | |
| Gross Profit | $1.2M | $1M | $414K | -- | -- | |
| Gross Profit Margin | 52.27% | 40.13% | 24.11% | -- | -- | |
| R&D Expenses | $312K | $702K | $708K | $5.6M | $12M | |
| Selling, General & Admin | $1.6M | $2.6M | $3.9M | $4.5M | $7M | |
| Other Inc / (Exp) | -- | -- | -- | -$12K | -- | |
| Operating Expenses | $2M | $3.3M | $4.6M | $9.8M | $18.6M | |
| Operating Income | -$714K | -$2.3M | -$4.2M | -$9.8M | -$18.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$713K | -$2.2M | -$4.1M | -$9.6M | -$15.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$784K | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$713K | -$2.2M | -$4.1M | -$10.4M | -$15.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$713K | -$2.2M | -$4.1M | -$10.4M | -$15.1M | |
| Basic EPS (Cont. Ops) | -$0.10 | -$0.20 | -$0.30 | -$0.37 | -$0.21 | |
| Diluted EPS (Cont. Ops) | -$0.10 | -$0.20 | -$0.30 | -$0.37 | -$0.21 | |
| Weighted Average Basic Share | $6.9M | $14.2M | $14.2M | $28.1M | $70.6M | |
| Weighted Average Diluted Share | $6.9M | $14.2M | $14.2M | $28.1M | $70.6M | |
| EBITDA | -$680K | -$2.2M | -$4.1M | -$9.3M | -$14.4M | |
| EBIT | -$714K | -$2.3M | -$4.2M | -$9.6M | -$15.1M | |
| Revenue (Reported) | $2.4M | $2.6M | $1.7M | $1.9M | -- | |
| Operating Income (Reported) | -$714K | -$2.3M | -$4.2M | -$9.8M | -$18.6M | |
| Operating Income (Adjusted) | -$714K | -$2.3M | -$4.2M | -$9.6M | -$15.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.7M | $10.2M | $9.9M | $7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.6M | $5.3M | $5.9M | -- | -- | |
| Gross Profit | $5.1M | $4.9M | $4M | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.2M | $1.8M | $2.6M | $14.9M | $35.8M | |
| Selling, General & Admin | $7.3M | $8.1M | $10.7M | $20M | $23.3M | |
| Other Inc / (Exp) | -- | -$9K | -- | -$34K | $13K | |
| Operating Expenses | $8.5M | $9.9M | $13.3M | $33.9M | $57.6M | |
| Operating Income | -$3.4M | -$5M | -$9.3M | -$33.5M | -$57.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$3.3M | -$4.9M | -$9.1M | -$32.5M | -$49.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$3.9M | -$6.1M | |
| Income Tax Expense | -- | -- | -- | -- | $7.8M | |
| Net Income to Company | -$3.3M | -$4.9M | -$9.1M | -$25.9M | -$63.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.3M | -$4.9M | -$9.1M | -$25.9M | -$63.8M | |
| Basic EPS (Cont. Ops) | -$0.50 | -$0.50 | -$0.60 | -$1.07 | -$1.46 | |
| Diluted EPS (Cont. Ops) | -$0.50 | -$0.50 | -$0.60 | -$1.07 | -$1.46 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$3.2M | -$4.8M | -$9.1M | -$31.9M | -$47.8M | |
| EBIT | -$3.4M | -$5M | -$9.3M | -$32.6M | -$49.7M | |
| Revenue (Reported) | $9.7M | $10.2M | $9.9M | $7M | -- | |
| Operating Income (Reported) | -$3.4M | -$5M | -$9.3M | -$33.5M | -$57.6M | |
| Operating Income (Adjusted) | -$3.4M | -$5M | -$9.3M | -$32.6M | -$49.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.9M | $7.1M | $1.9M | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.1M | $4.4M | -- | -- | -- | |
| Gross Profit | $3.7M | $2.8M | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.5M | $2.1M | $14.2M | $28.8M | -- | |
| Selling, General & Admin | $6.3M | $8.4M | $16.1M | $18.4M | -- | |
| Other Inc / (Exp) | -$2K | -- | -$34K | -$6K | -- | |
| Operating Expenses | $7.9M | $10.5M | $29.2M | $45.9M | -- | |
| Operating Income | -$4.1M | -$7.7M | -$29.2M | -$45.9M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$4M | -$7.5M | -$28.5M | -$38.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -$3.9M | -$890K | -- | |
| Income Tax Expense | -- | -- | -$10.5M | -- | -- | |
| Net Income to Company | -$4M | -$7.5M | -$21.8M | -$39.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4M | -$7.5M | -$21.8M | -$39.1M | -- | |
| Basic EPS (Cont. Ops) | -$0.40 | -$0.50 | -$0.77 | -$0.59 | -- | |
| Diluted EPS (Cont. Ops) | -$0.40 | -$0.50 | -$0.77 | -$0.59 | -- | |
| Weighted Average Basic Share | $40.6M | $42.6M | $78.9M | $186.8M | -- | |
| Weighted Average Diluted Share | $40.6M | $42.6M | $78.9M | $186.8M | -- | |
| EBITDA | -$4M | -$7.5M | -$27.7M | -$36.5M | -- | |
| EBIT | -$4.1M | -$7.7M | -$28.4M | -$38M | -- | |
| Revenue (Reported) | $7.9M | $7.1M | $1.9M | -- | -- | |
| Operating Income (Reported) | -$4.1M | -$7.7M | -$29.2M | -$45.9M | -- | |
| Operating Income (Adjusted) | -$4.1M | -$7.7M | -$28.4M | -$38M | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $21M | $9.2M | |
| Short Term Investments | -- | -- | -- | $22.8M | -- | |
| Accounts Receivable, Net | -- | -- | -- | $1.4M | $1.2M | |
| Inventory | -- | -- | -- | $1.4M | -- | |
| Prepaid Expenses | -- | -- | -- | $548K | $1.1M | |
| Other Current Assets | -- | -- | -- | $27K | $45K | |
| Total Current Assets | -- | -- | -- | $53.2M | $16.8M | |
| Property Plant And Equipment | -- | -- | -- | $2.1M | $6.3M | |
| Long-Term Investments | -- | -- | -- | $150K | $133K | |
| Goodwill | -- | -- | -- | -- | $24.1M | |
| Other Intangibles | -- | -- | -- | $86K | $50.4M | |
| Other Long-Term Assets | -- | -- | -- | $2.6M | $182K | |
| Total Assets | -- | -- | -- | $58.1M | $97.9M | |
| Accounts Payable | -- | -- | -- | $1.5M | $6.1M | |
| Accrued Expenses | -- | -- | -- | $574K | $3.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $49K | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $276K | $46K | |
| Other Current Liabilities | -- | -- | -- | -- | $5.1M | |
| Total Current Liabilities | -- | -- | -- | $2.7M | $15.7M | |
| Long-Term Debt | -- | -- | -- | -- | $1.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $3.4M | $22.7M | |
| Common Stock | -- | -- | -- | $142K | $282K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | $54.6M | $75.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $54.6M | $75.2M | |
| Total Liabilities and Equity | -- | -- | -- | $58.1M | $97.9M | |
| Cash and Short Terms | -- | -- | -- | $43.8M | $9.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.9M | $61.7M | $19M | $18M | $226.4M | |
| Short Term Investments | -- | -- | $35.1M | -- | $41.4M | |
| Accounts Receivable, Net | $1.8M | $1.9M | $1.2M | $1.7M | $217K | |
| Inventory | $641K | $1.1M | $1.6M | $1M | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $407K | $306K | $662K | $961K | $2.1M | |
| Total Current Assets | $4.7M | $65M | $57.5M | $21.7M | $270.2M | |
| Property Plant And Equipment | $2.8M | $2.7M | $2.4M | $8.5M | $46.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $27.3M | $24.1M | |
| Other Intangibles | -- | -- | -- | $50M | $50M | |
| Other Long-Term Assets | $514K | $1.1M | $2.6M | $3M | $694K | |
| Total Assets | $8M | $68.7M | $62.5M | $110.5M | $391.2M | |
| Accounts Payable | $758K | $768K | $2.5M | $3.9M | $21.8M | |
| Accrued Expenses | $301K | $522K | $963K | $3.4M | $4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $48K | $51K | |
| Current Portion Of Capital Lease Obligations | $241K | $256K | $272K | $293K | $903K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5M | $1.8M | $4M | $8.1M | $28.1M | |
| Long-Term Debt | -- | -- | -- | $1.7M | $1.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.9M | $3M | $4.8M | $11.7M | $62.7M | |
| Common Stock | $69K | $142K | $142K | $281K | $67K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.1M | $65.8M | $57.7M | $98.8M | $328.5M | |
| Total Liabilities and Equity | $8M | $68.7M | $62.5M | $110.5M | $391.2M | |
| Cash and Short Terms | $1.9M | $61.7M | $54.1M | $18M | $267.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$7.3M | -$46.5M | |
| Depreciation & Amoritzation | -- | -- | -- | $138K | $946K | |
| Stock-Based Compensation | -- | -- | -- | $672K | $3.7M | |
| Change in Accounts Receivable | -- | -- | -- | $245K | -$426K | |
| Change in Inventories | -- | -- | -- | -$76K | $359K | |
| Cash From Operations | -- | -- | -- | -$6.1M | -$36.9M | |
| Capital Expenditures | -- | -- | -- | $151K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | $2.7M | |
| Cash From Investing | -- | -- | -- | -$28.8M | $24.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$68K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$65K | |
| Cash From Financing | -- | -- | -- | $28K | $785K | |
| Beginning Cash (CF) | -- | -- | -- | $56.1M | $21.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$34.9M | -$11.8M | |
| Ending Cash (CF) | -- | -- | -- | $21.2M | $9.4M | |
| Levered Free Cash Flow | -- | -- | -- | -$6.2M | -$38M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$713K | -$2.2M | -$4.1M | -$10.4M | -$15.1M | |
| Depreciation & Amoritzation | $34K | $59K | $68K | $259K | $669K | |
| Stock-Based Compensation | $85K | $596K | $465K | $451K | $2M | |
| Change in Accounts Receivable | $286K | $111K | $395K | -$618K | -$133K | |
| Change in Inventories | -$63K | -$796K | -$95K | $113K | -- | |
| Cash From Operations | -$338K | -$2.1M | -$1.8M | -$10.1M | $3.4M | |
| Capital Expenditures | $113K | $54K | $90K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$113K | -$54K | -$35.2M | -$227K | -$29.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$21K | -$16K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $28K | $1K | $628K | |
| Beginning Cash (CF) | $2.6M | $64M | $56.1M | $28.5M | $252.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$451K | -$2.1M | -$36.9M | -$10.3M | -$25.7M | |
| Ending Cash (CF) | $2.1M | $61.9M | $19.2M | $18.2M | $226.4M | |
| Levered Free Cash Flow | -$451K | -$2.1M | -$1.9M | -$10.3M | -$26.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.3M | -$4.9M | -$9.1M | -$25.9M | -$63.8M | |
| Depreciation & Amoritzation | $143K | $174K | $257K | $752K | $1.8M | |
| Stock-Based Compensation | $489K | $897K | $956K | $3.5M | $4M | |
| Change in Accounts Receivable | -$237K | -$144K | $689K | $27K | $832K | |
| Change in Inventories | -$199K | -$1M | -$2M | $162K | $113K | |
| Cash From Operations | -$3.3M | -$4.6M | -$7.4M | -$29.7M | -$696K | |
| Capital Expenditures | $288K | $322K | $302K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | $2.7M | -- | |
| Cash From Investing | -$302K | -$351K | -$35.4M | -$10.7M | -$80.4M | |
| Dividends Paid (Ex Special Dividend) | -$11K | -$9K | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$48K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $64.7M | $84K | $461K | $289.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.6M | $59.8M | -$42.7M | -$39.9M | $208.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$3.6M | -$4.9M | -$7.7M | -$30.7M | -$40.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4M | -$7.5M | -$21.8M | -$39.1M | -- | |
| Depreciation & Amoritzation | $137K | $197K | $684K | $1.6M | -- | |
| Stock-Based Compensation | $816K | $776K | $3M | $3.3M | -- | |
| Change in Accounts Receivable | -$164K | $434K | -$368K | $890K | -- | |
| Change in Inventories | -$985K | -$2M | $257K | $11K | -- | |
| Cash From Operations | -$3.8M | -$6.1M | -$27.9M | $8.3M | -- | |
| Capital Expenditures | $262K | $221K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | $2.7M | -- | -- | |
| Cash From Investing | -$291K | -$35.3M | $24.5M | -$80.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$56K | -$36K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$65K | -- | -- | |
| Cash From Financing | $56.2M | $28K | $433K | $289M | -- | |
| Beginning Cash (CF) | $138.8M | $175.7M | $86.3M | $403.9M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $52.1M | -$41.4M | -$3M | $217M | -- | |
| Ending Cash (CF) | $190.9M | $134.3M | $83.3M | $620.9M | -- | |
| Levered Free Cash Flow | -$4.1M | -$6.3M | -$28.9M | -$31.5M | -- | |
Get CATX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CATX
Sector
P/E ratio
--
24.13x
PEG ratio
-0.22x
0.00x
P/B ratio
0.53x
1.69x
Price / LTM sales
13.99x
1.71x
Growth Metrics
CATX
Sector
Revenue growth
--
6.54%
Earnings growth
--
6.3%
Revenue (5-year growth)
--
9.13%
Earnings forecast
-$0.25
-$0.20
Profitability
CATX
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.96%
Return on assets
--
-12.4%
Return on equity
--
-17.27%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
28
Estimated Next Earnings Date
Feb
11
Balance Sheet
CATX
Sector
Total cash
$267.8M
$44.5M
Short term investments
--
$39.2M
Total assets
$97.9M
$126.6M
Long term debt
--
$9.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
